Aigen Investment Management, LP United Therapeutics Corp Transaction History

Aigen Investment Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$184.32 - $216.08 $253,992 - $297,758	-1,378 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$179.86 - $214.88 $247,847 - $296,104	1,378 New	1,378 $254,000
Q2 2020 Aug 10, 2020	SELL	$92.74 - $125.82 $13,911 - $18,873	-150 Closed	0 $0
Q1 2020 May 08, 2020	SELL	$79.39 - $115.35 $140,679 - $204,400	-1,772 Reduced 92.2%	150 $14,000
Q4 2019 Feb 04, 2020	BUY	$78.31 - $95.34 $150,511 - $183,243	1,922 New	1,922 $169,000

719

60.7M

181K

158K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.9B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.